Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma

Long-acting beta-agonists in asthma management: What is the current status?

Mysore, S.
Ruffin, R.

January 2011

Large surveillance studies or phase IV clinical studies of long-acting β-agonists (LABA) compared wi...

Long-acting β2-adrenergic receptor agonist in pediatric asthma

Yoshihara, Shigemi
Yamada, Yumi
Abe, Toshio
Arisaka, Osamu

December 2004

ABSTRACTLong-acting β2-adrenergic receptor agonists (LABA), a class of agents for the long-term mana...

Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma.

Vaessen-Verberne, A.A.
Berg, N.J. van den
Nierop, J.C. van
Brackel, H.J.
Gerrits, G.P.J.M.
Hop, W.C.J.
Duiverman, E.J.

January 2010

Item does not contain fulltextRATIONALE: For children with symptomatic asthma despite low to moderat...

Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma

Stempel, DA
Szefler, SJ
Pedersen, S
Zeiger, RS
Yeakey, AM
Lee, LA
Liu, AH
Mitchell, H
Kral, KM
Prillaman, BA
Buaron, KS
Yun Kirby, S
Pascoe, SJ
VESTRI Investigators

January 2016

Long-acting beta-agonists (LABAs) have been shown to increase the risk of asthma-related death among...

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone

Stempel, D.
Raphiou, I.
Kral, K.
Yeakey, A.
Emmett, A.
Prazma, C.
Buaron, K.
Pascoe, S. Scichilone N tra i collaboratori

January 2016

BACKGROUND The safe and appropriate use of long-acting beta-agonists (LABAs) for the treatment of as...

Published Online First

January 2010

Background The safety of long-acting β 2 agonist (LABA) therapy in asthma remains controversial but ...

Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies

Hernández, Gimena
Ávila Pacheco, Mónica Marcela, 1984-
Pont Acuña, Àngels
Garin Boronat, Olatz, 1979-
Alonso Caballero, Jordi
Laforest, Laurent
Cates, Christopher J.
Ferrer Forés, Maria Montserrat
ASTRO-LAB group

Background: Although several systematic reviews investigated the safety of long-acting beta–agonists...

Serious asthma events with fluticasone plus salmeterol versus fluticasone alone

Stempel, David A.
Raphiou, Ibrahim H.
Kral, Kenneth M.
Yeakey, Anne M.
Emmett, Amanda H.
Prazma, Charlene
Buaron, Kathleen S.
Pascoe, Steven J.
Lores Obradors, Luis
AUSTRI Investigators

June 2021

Background: the safe and appropriate use of long-acting beta-agonists (LABAs) for the treatment of a...

Safety of formoterol in children and adolescents: experience from asthma clinical trials

Price, J. F.
Radner, F.
Lenney, W.
Lindberg, Bengt

January 2010

Background The safety of long-acting beta(2) agonist (LABA) therapy in asthma remains controversial ...

Safety of long-acting ß2-agonists in the treatment of asthma

CAZZOLA, MARIO
Matera M. G.

January 2007

Several studies suggested an association between the regular use of Î²2-agonists and asthma deaths. ...

Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials

Sears, Malcolm R.
Radner, Finn

December 2009

SummaryBackgroundThe safety of long-acting β2-agonists (LABAs) in asthma is debated. This study exam...

Are inhaled long-acting beta-agonists (LABA) really harmful in adult asthmatics?

Husna Zayadi

Asthmatic patients should be explained that FDA recently issued a black box warning regarding use of...

Benefit-risk assessment of long-acting beta(2)-agonists in asthma

Jackson, C M
Lipworth, B

January 2004

The use of a regular long-acting beta(2)-adrenoceptor agonists (beta(2)-agonists; LABA) is now estab...

Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid

Walters, E Haydn
Gibson, Peter G
Lasserson, Toby J
Walters, Julia AE

January 2007

Background: Asthma is a common respiratory disease among both adults and children and short acting i...

Efficacy and Safety of Salmeterol/fluticasone Combination Therapy in Infants and Preschool Children with Asthma Insufficiently Controlled by Inhaled Corticosteroids

Yoshihara, S.
Fukuda, H.
Tamura, M.
Arisaka, O.
Ikeda, M.
Fukuda, N.
Tsuji, T.
Hasegawa, S.
Kanno, N.
Teraoka, M.
Wakiguchi, H.
Aoki, Y.
Terada, A.
Hasegawa, M.
Manki, A.
Igarashi, H.

July 2016

Background: Clinical evidences of inhaled salmeterol/fluticasone propionate combination (SFC) therap...

Long-acting beta-agonists in asthma management: What is the current status?

Mysore, S.
Ruffin, R.

January 2011

Large surveillance studies or phase IV clinical studies of long-acting β-agonists (LABA) compared wi...

Long-acting β2-adrenergic receptor agonist in pediatric asthma

Yoshihara, Shigemi
Yamada, Yumi
Abe, Toshio
Arisaka, Osamu

December 2004

ABSTRACTLong-acting β2-adrenergic receptor agonists (LABA), a class of agents for the long-term mana...

Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma.

Vaessen-Verberne, A.A.
Berg, N.J. van den
Nierop, J.C. van
Brackel, H.J.
Gerrits, G.P.J.M.
Hop, W.C.J.
Duiverman, E.J.

January 2010

Item does not contain fulltextRATIONALE: For children with symptomatic asthma despite low to moderat...

Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma

Stempel, DA
Szefler, SJ
Pedersen, S
Zeiger, RS
Yeakey, AM
Lee, LA
Liu, AH
Mitchell, H
Kral, KM
Prillaman, BA
Buaron, KS
Yun Kirby, S
Pascoe, SJ
VESTRI Investigators

January 2016

Long-acting beta-agonists (LABAs) have been shown to increase the risk of asthma-related death among...

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone

Stempel, D.
Raphiou, I.
Kral, K.
Yeakey, A.
Emmett, A.
Prazma, C.
Buaron, K.
Pascoe, S. Scichilone N tra i collaboratori

January 2016

BACKGROUND The safe and appropriate use of long-acting beta-agonists (LABAs) for the treatment of as...

Published Online First

January 2010

Background The safety of long-acting β 2 agonist (LABA) therapy in asthma remains controversial but ...

Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies

Hernández, Gimena
Ávila Pacheco, Mónica Marcela, 1984-
Pont Acuña, Àngels
Garin Boronat, Olatz, 1979-
Alonso Caballero, Jordi
Laforest, Laurent
Cates, Christopher J.
Ferrer Forés, Maria Montserrat
ASTRO-LAB group

Background: Although several systematic reviews investigated the safety of long-acting beta–agonists...

Serious asthma events with fluticasone plus salmeterol versus fluticasone alone

Stempel, David A.
Raphiou, Ibrahim H.
Kral, Kenneth M.
Yeakey, Anne M.
Emmett, Amanda H.
Prazma, Charlene
Buaron, Kathleen S.
Pascoe, Steven J.
Lores Obradors, Luis
AUSTRI Investigators

June 2021

Background: the safe and appropriate use of long-acting beta-agonists (LABAs) for the treatment of a...

Safety of formoterol in children and adolescents: experience from asthma clinical trials

Price, J. F.
Radner, F.
Lenney, W.
Lindberg, Bengt

January 2010

Background The safety of long-acting beta(2) agonist (LABA) therapy in asthma remains controversial ...

Safety of long-acting ß2-agonists in the treatment of asthma

CAZZOLA, MARIO
Matera M. G.

January 2007

Several studies suggested an association between the regular use of Î²2-agonists and asthma deaths. ...

Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials

Sears, Malcolm R.
Radner, Finn

December 2009

SummaryBackgroundThe safety of long-acting β2-agonists (LABAs) in asthma is debated. This study exam...

Are inhaled long-acting beta-agonists (LABA) really harmful in adult asthmatics?

Husna Zayadi

Asthmatic patients should be explained that FDA recently issued a black box warning regarding use of...

Benefit-risk assessment of long-acting beta(2)-agonists in asthma

Jackson, C M
Lipworth, B

January 2004

The use of a regular long-acting beta(2)-adrenoceptor agonists (beta(2)-agonists; LABA) is now estab...

Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid

Walters, E Haydn
Gibson, Peter G
Lasserson, Toby J
Walters, Julia AE

January 2007

Background: Asthma is a common respiratory disease among both adults and children and short acting i...

Efficacy and Safety of Salmeterol/fluticasone Combination Therapy in Infants and Preschool Children with Asthma Insufficiently Controlled by Inhaled Corticosteroids

Yoshihara, S.
Fukuda, H.
Tamura, M.
Arisaka, O.
Ikeda, M.
Fukuda, N.
Tsuji, T.
Hasegawa, S.
Kanno, N.
Teraoka, M.
Wakiguchi, H.
Aoki, Y.
Terada, A.
Hasegawa, M.
Manki, A.
Igarashi, H.

July 2016

Background: Clinical evidences of inhaled salmeterol/fluticasone propionate combination (SFC) therap...

Long-acting beta-agonists in asthma management: What is the current status?

Mysore, S.
Ruffin, R.

January 2011

Large surveillance studies or phase IV clinical studies of long-acting β-agonists (LABA) compared wi...

Long-acting β2-adrenergic receptor agonist in pediatric asthma

Yoshihara, Shigemi
Yamada, Yumi
Abe, Toshio
Arisaka, Osamu

December 2004

ABSTRACTLong-acting β2-adrenergic receptor agonists (LABA), a class of agents for the long-term mana...

Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma.

Vaessen-Verberne, A.A.
Berg, N.J. van den
Nierop, J.C. van
Brackel, H.J.
Gerrits, G.P.J.M.
Hop, W.C.J.
Duiverman, E.J.

January 2010

Item does not contain fulltextRATIONALE: For children with symptomatic asthma despite low to moderat...

Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma

Abstract

Extracted data

Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma

Abstract

Extracted data

Related items

Related items